Supha Pharmachem LtdBSE: SUPHA

Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Remedium Lifecare Limited Held On 24Th April, 2025

· Issued by Supha Pharmachem Ltd via BSE India

Filed with BSE ·

The Board of Directors of the Company at its meeting held today, i.e. April 24, 2025 have considered and approved inter alia the following:1. The Letter of Offer, Abridged Letter of Offer, Rights Entitlement Letter, Application Form and other issue related terms and documents.The Letter of Offer to be filed with BSE Limited.2. Rights Issue Period: ISSUE OPENING DATE APRIL 30, 2025ISSUE CLOSING DATE May 14, 2025

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Supha Pharmachem Ltd on 6ix

Earlier from Supha Pharmachem

Later from Supha Pharmachem

All Supha Pharmachem news releases